HIV & AIDS

Candidate AIDS vaccine passes early test

The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

HIV & AIDS

HIV expert's studies yielding insights into diseases of aging

While AIDS originally was seen as an adaptive immune disease, the research of Alan Landay, PhD, has contributed to a view of it as a cell driven-inflammation linked to immunosenescence—the gradual deterioration of the immune ...

HIV & AIDS

Pillar of HIV prevention (PrEP)—how to implement

A pillar of the federal government's plans to fight the HIV epidemic is PrEP: pre-exposure prophylaxis. For someone who is HIV-negative but at risk of becoming infected, this means taking anti-retroviral drugs before possible ...

HIV & AIDS

Bringing a new perspective to infectious disease

Studying infectious diseases has long been primarily the domain of biologists. However, as part of the Ragon Institute, MIT engineers and physical scientists are joining immunologists and physicians in the battle against ...

HIV & AIDS

More support needed to increase HIV testing in GP practices

One-off training sessions for GPs are not enough to increase rates of HIV testing in general practice and greater support is needed, according to researchers from the University of Bristol's Centre for Academic Primary Care ...

page 8 from 13